Advertisement

Topics

Latest "Fibrocell Science FCSC Medical Equipment Deals Alliances Profile" News Stories

09:27 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Fibrocell Science FCSC Medical Equipment Deals Alliances Profile" found in our extensive news archives from over 250 global news sources.

More Information about Fibrocell Science FCSC Medical Equipment Deals Alliances Profile on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Fibrocell Science FCSC Medical Equipment Deals Alliances Profile for you to read. Along with our medical data and news we also list Fibrocell Science FCSC Medical Equipment Deals Alliances Profile Clinical Trials, which are updated daily. BioPortfolio also has a large database of Fibrocell Science FCSC Medical Equipment Deals Alliances Profile Companies for you to search.

Showing "Fibrocell Science FCSC Medical Equipment Deals Alliances Profile" News Articles 1–25 of 34,000+

Wednesday 20th March 2019

Brainlab Acquires Robotics Platform Company Medineering

Brainlab creates first openly scalable medical robotics platform paired with an efficient software ecosystem Brainlab, a global pioneer of software-driven medical technology, announced today the acquisition of


Fresenius Medical Care appoints Dr. Frank Maddux as Global Chief Medical Officer

DGAP-News: Fresenius Medical Care AG & Co. KGaA / Key word(s): Miscellaneous 20.03.2019 / 13:04 The issuer is solely responsible for the content of this announcement. Fresenius Medical Care, the world's largest provider of dialysis products and services, announced today that it has appointed Dr. Frank Maddux as Global Chief Medical Officer. With this newly created position the company f...

DionyMed Brands Inc. Signs Binding Term Sheet to Acquire 1.83 Acre Southern California Cannabis Campus from MMAC

DionyMed Strengthens Distribution and Direct-to-Consumer Platform in the Los Angeles Market DionyMed Brands Inc. (“DionyMed” or “Company”) (CSE: DYME), a multi-state cannabis brands platform, announced today it has signed a binding term sheet with MM Esperanza 2 LLC, doing business as “MMAC,” to acquire select MMAC assets (the “Acquisitio...


iVantage Health Analytics Launches Breakthrough Platform to Help Health Systems and Physician Leaders Optimize Medical Group Performance

Physician Enterprise Performance Manager is the Industry’s First Integrated Benchmarking & Performance Management Platform Analyzing Patient Access and Cost Data iVantage Health Analytics, a leading provider of performance management and analytic solutions for hospitals and healthcare systems, announced the launch of a new ...

Vixiar Medical Raises $1.5 Million in Additional Financing

New and existing investors fund company through planned FDA submission for Indicor™, a non-invasive, point-of-care device for estimating cardiac filling pressure. Vixiar Medical, Inc., a privately held Maryland company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary diseases, announced today that it clo...

Fishawack continues to build best-in-class service offering with Dudnyk acquisition

Fishawack, a leading independent healthcare communications specialist, is excited to announce its acquisition of Dudnyk, the Philadelphia-based healthcare communications agency. Dudnyk is an award-winning, full-service agency that specializes in creating insight-driven, authentic brand experiences that unite specialty physicians and their patients. They le...

Industry Consortium Launched to Qualify Biomarkers for Schizophrenia Drug Development

Group Aims to Bring Disease-Associated Biomarker Through FDA’s Drug Development Tools Qualification Program The ERP Biomarker Qualification Consortium was launched today by pharmaceutical industry members with the goal of qualifying event-related potential (ERP) biomarkers to aid the development of new investigational therapies for people with schizo...

Natreon is Granted a U.S. Patent on its CROMINEX® Product

A new patent has been added to Natreon's clinically studied ingredient, Crominex®3+, as it relates to its cardiovascular health benefits. NEW BRUNSWICK, N.J. (PRWEB) March 20, 2019 Natreon has been granted a U.S. Patent (10,183,047, January 22, 2019) on its Crominex®3+, a composition of trivalent chromium chloride combined with extracts of amla and shilajit, that has a synergistic e...

Private health screening: NHS must not be left to “pick up the pieces,” say LMCs

Private screening providers should be mandated to provide follow-up appointments with patients to discuss abnormal results and should not offload responsibility to the NHS, local medical committees...

ConnectedLife and Ocean Protocol Partner to combat Parkinson's Disease

SINGAPORE, March 20, 2019 /PRNewswire/ -- ConnectedLife and Ocean Protocol announce their partnership to advance Parkinson's Disease diagnosis and treatment with safe sharing of patient-generated data. Ocean Protocol Founder, Trent McConaghy By combining

KCU Names Vice Provost for Oral Health Initiatives in Joplin

Kansas City University is committed to establishing a College of Dental Medicine on our Farber-McIntire Campus in Joplin Missouri. We will soon be completing our due diligence process and expect to be making a public announcement shortly. The hiring of Dr. Koelbl, a nationally recognized expert in dental education, is but one step towards the establishment of a world-class College of Dental Medi...

Nimbus Therapeutics Grows Scientific Team, Adding Leaders in Biology and Preclinical Development

Nimbus Therapeutics, a biotechnology company applying deep computational expertise throughout drug discovery and development, today announced the addition of two experts in drug discovery and development to its leadership team. Alan Collis, Ph.D., who was formerly Executive Director of DMPK at Forma Therapeutics, joined the Nimbus team part...

Cydan Expands Team to Accelerate Development of Innovative Treatments for Patients Living with Rare Diseases

Yongchang Qiu, Ph.D., Named Vice President, Preclinical Development; Ryan Tyler, Ph.D., Named Senior Director, Preclinical Research; Niels Svenstrup, Ph.D., Promoted to Senior Vice President, Development Heather Halem, Ph.D., Named a Cydan Fellow Cydan, an orphan drug accelerator dedicated to creating therapies that improve the lives of p...

Awareness of HCV Testing Recommendation Among Baby Boomers

Are baby boomers--those born from1945 to 1965--familiar with the CDC's recommendations for HCV testing in their age group? Southern Medical Journal

A Rare Cause of Back Pain and Radiculopathy -- Spinal Tophi

This patient's back pain and radiculopathy was initially misdiagnosed as an epidural abscess and spondylodiscitis. What was discovered upon surgery? Journal of Medical Case Reports

Sally Davies: Silk, noir, and diplomacy

bmj;364/mar20_4/l1201/FAF1faDuncan SmithBiographySally Davies, chief medical officer for England, will become master of Trinity College Cambridge in October,1 the first woman to hold the post in the...

GP suicides: LMCs call for action to reduce “appalling” numbers

The BMA’s General Practitioners Committee (GPC) must lobby ministers for increased psychological support for GPs to reduce the “appalling” number of doctor suicides, local medical committees have...

Medical robotics firm Neural Analytics enrolls first subject in CODEX study

The study, which is being carried out at the Ochsner Clinical Foundation in New Orleans, Louisiana, uses an investigational iteration of the Lucid Robotic System (Lucid M1 Transcranial The post Medical robotics firm Neural Analytics enrolls first subject in CODEX study appeared first on Compelo Medical Devices - Latest industry news and analysis.

Three studies demonstrate clinical utility of AliveCor’s mobile ECG platform

AliveCor claims that its KardiaMobile is recommended by leading cardiologists and used by people worldwide for accurate ECG recordings. KardiaBand is also the first FDA-cleared medical device accessory The post Three studies demonstrate clinical utility of AliveCor’s mobile ECG platform appeared first on Compelo Medical Devices - Latest industry news and analysis.

Oncimmune buys personalized immuno-profiling firm Protagen Diagnostics

Oncimmune acquired the firm for a total consideration of up to £4.11m, to be paid by the allotment of up to 2,635,910 Oncimmune Ordinary Shares at 156p per The post Oncimmune buys personalized immuno-profiling firm Protagen Diagnostics appeared first on Compelo Medical Devices - Latest industry news and analysis.

ForaCare launches new diabetes monitoring system

The innovative product is expected to give patients, and the providers who care for them, a uniquely effective and efficient means of managing high-risk diabetes. FORA GTel provides The post ForaCare launches new diabetes monitoring system appeared first on Compelo Medical Devices - Latest industry news and analysis.

One Drop partners with Amazon’s Choice to expand health services offering

Through this partnership, One Drop and Amazon’s Choice will bring affordable, accessible, and comprehensive digital health management services to Amazon’s Choice customers living with diabetes and hypertension nationwide. The post One Drop partners with Amazon’s Choice to expand health services offering appeared first on Compelo Medical Devices - Latest industry news and analysi...

Eos Biosciences Issued Patent for New Approach to Shuttle Therapeutics Across the Blood-Brain Barrier to Treat Brain Diseases

Eos Biosciences, Inc. (Eos), a nanomedicines company developing an efficient and versatile nanobiologic particle-based platform technology (Eosomes), announced that the U.S. Patent and Trademark Office has granted Eos Biosciences Patent No. 10,183,078, relating to a novel approach of using HER3-targeted Eosomes as a shuttle system for transporting v...

Metal Coated Substrates for Characterizing Self-assembled Monolayers

Product AnnouncementAMSBIO's expanding range of noble metal coating services provides customized solutions in surface science for industrial and academic researchers.

Dyve Bioscience Announces Positive Results from Pilot Study in Gout Pain at European Crystal Network Workshop 2019

Topical, transdermal sodium bicarbonate treatment significantly and safely reduced pain associated with an acute gout flare Dyve Bioscience, a biotech drug delivery company developing novel transdermal technologies for delivery of molecules through the skin, announced positive results from a human proof-of-concept pilot study of transdermal sodium bica...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks